Advances in pleural disease
Authors:
- Veena B. AntonyVAVeena B. Antony
- 1 June 2007
- journal article
- review article
- Published by Elsevier in Drug Discovery Today: Disease Mechanisms
- Vol. 4 (2) , 103-108
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Diagnostic biomarker of asbestos‐related mesothelioma: Example of translational researchCancer Science, 2007
- Utility of Osteopontin and Serum Mesothelin in Malignant Pleural Mesothelioma Diagnosis and Prognosis AssessmentClinical Cancer Research, 2007
- Talc mediates angiostasis in malignant pleural effusionsviaendostatin inductionEuropean Respiratory Journal, 2007
- SV40 and human cancer: A review of recent dataInternational Journal of Cancer, 2006
- Silencing the receptor EphA2 suppresses the growth and haptotaxis of malignant mesothelioma cellsCancer, 2006
- Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamstersProceedings of the National Academy of Sciences, 2006
- Megakaryocyte Potentiation Factor Cleaved from Mesothelin Precursor Is a Useful Tumor Marker in the Serum of Patients with MesotheliomaClinical Cancer Research, 2006
- TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesisProceedings of the National Academy of Sciences, 2006
- Genetic Predisposition to Fiber Carcinogenesis Causes a Mesothelioma Epidemic in TurkeyCancer Research, 2006
- Evidence against a Role for SV40 in Human MesotheliomaCancer Research, 2005